Form 4: Insmed COO Roger Adsett Sells Shares for Tax Obligations

Insmed Incorporated Chief Operating Officer Roger Adsett sold 2,370 shares of common stock to cover tax withholding obligations.

Summary

• Roger Adsett, Chief Operating Officer of Insmed Inc, sold 2,370 shares of common stock on June 3, 2026.
• The shares were sold at a price of $102.27 per share.
• Following the transaction, the reporting person retains beneficial ownership of 98,603 shares.
• The sale was executed to satisfy tax withholding obligations related to the vesting of Restricted Stock Units.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale is purely administrative and related to tax obligations rather than a strategic shift.

Positives

• The transaction was a routine sale to cover tax liabilities rather than a discretionary divestment of holdings.

Negatives

• Reduction in the direct equity stake held by a key executive.

Risks

• None identified in this filing.

Future Outlook

No forward-looking guidance provided in this filing.

Management Comments

• The sale was conducted to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Industry Context

StockSavvy.ai notes that routine insider sales to cover tax obligations upon RSU vesting are standard corporate practice and generally do not signal a change in management sentiment regarding company performance.

Comparison to Industry Standards

• The transaction aligns with standard executive compensation practices in the biotechnology sector where equity-based incentives are common.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was non-discretionary.

Next Steps

• None mentioned.

Key Dates

Keywords

Insmed, INSM, Insider Trading, Form 4, Biotech, Executive Compensation